The PP2A inhibitor LB-100 mitigates lupus nephritis by suppressing tertiary lymphoid structure formation.

MLA

Yang, Hongyu, et al. “The PP2A Inhibitor LB-100 Mitigates Lupus Nephritis by Suppressing Tertiary Lymphoid Structure Formation.” European Journal of Pharmacology, vol. 977, Aug. 2024, p. 176703. EBSCOhost, https://doi.org/10.1016/j.ejphar.2024.176703.

APA

Yang, H., Luo, X., Wang, X., Peng, Y., Li, Z., He, Y., Cong, J., Xie, T., & Zhang, W. (2024). The PP2A inhibitor LB-100 mitigates lupus nephritis by suppressing tertiary lymphoid structure formation. European Journal of Pharmacology, 977, 176703. https://doi.org/10.1016/j.ejphar.2024.176703

Chicago

Yang, Hongyu, Xiaoyu Luo, Xuan Wang, Yi Peng, Zhilan Li, Yifei He, Jing Cong, Tingting Xie, and Weiru Zhang. 2024. “The PP2A Inhibitor LB-100 Mitigates Lupus Nephritis by Suppressing Tertiary Lymphoid Structure Formation.” European Journal of Pharmacology 977 (August): 176703. doi:10.1016/j.ejphar.2024.176703.